Positive data for Amylyx’s AMX0035 strengthen its position to enter ALS market
On October 16, Amylyx announced that AMX0035, its amyotrophic lateral sclerosis (ALS) pipeline drug, showed potential to prolong patient survival…
Latest Market Data
-
8 hours
-
3 days
-
1 week
-
1 week
-
8 hours
-
3 days
-
1 week
-
1 week
Trials disrupted due to Covid-19 continue to resume
Since early March, more than 500 companies have publicly announced clinical trial disruptions, both planned and ongoing, due to the…
Latest News
View More
Optimism over global economic recovery hits a low as May ends: Poll analysis
The global economic growth in 2020 has been eclipsed since the COVID-19 pandemic outbreak causing fears of looming unemployment and recession in a number of…
Signant Health launches partner programme to improve clinical trials
Zelboraf is indicated for the treatment of metastatic melanoma and Erdheim-Chester disease. The Signant Health Partner Program aims to enable CROs to better serve sponsors…
M&As this week: MabSpace Biosciences, Cambrex, Hetero Labs
MabSpace Biosciences has merged with HJB to create a fully-integrated biotherapeutics company named Transcenta Holding. Transcenta will have more than…
Deals this week: Antengene Corporation, Acer Therapeutics, Menarini
Antengene Corporation has raised $120m in a series B funding round led by Boyu Capital and FountainVest. The funding round…
Deals this week: DelSiTech, Marken, Erasca
DelSiTech has signed an agreement with Innovare for the development of long-acting human immunodeficiency virus (HIV) therapeutics. Innovare will make upfront…
M&As this week: 10x Genomics, Atlantic Research Group, AGC
10x Genomics has acquired Spatial Transcriptomics to enter the field of spatial genomics. The acquisition will enable 10x Genomics to gain…
Latest Content
View More
Novartis’ Intrathecal Zolgensma delay in older patients bodes well for competitors
Following a review of data from the Phase I STRONG study of the intrathecal (IT) formulation of Novartis’ one-off gene…
EASD 2020: Once-Weekly Basal Insulin Icodec Provides Comparable Efficacy and Safety to Once-Daily Insulin Glargine U100 in Insulin-Naïve Patients with Type 2 Diabetes Inadequately Controlled by OAD
At the 56th annual European Association for the Study of Diabetes (EASD) 2020 meeting, positive results were presented for Novo…
Real Time Cargo Intelligence to Increase Distribution Quality and Security
Smooth visibility from the place of production to the ultimate destination must be the new standard for vaccine delivery. The…
SIMPONI ARIA (golimumab) for the Treatment of Polyarticular Juvenile Idiopathic Arthritis (pJIA)
SIMPONI ARIA® (golimumab) is a fully human anti-tumour necrosis factor (TNF) alpha monoclonal antibody. It is indicated for the treatment…
SOM Biotech Announces Poster Presentation on the Repurposing of Eravacycline for the Treatment of SARS-CoV-2
SOM Biotech, a biopharmaceutical company specialising in the repositioning of existing drugs for the treatment of diseases with a high…
How the Formedix Visual Define.xml Editor Gives You Faster Define
Define.xml is the metadata that describes the content and formatting of submission datasets and the case report tabulation data. It’s…